• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Oric Pharmaceuticals, Inc. - Common Stock (NQ:ORIC)

    9.100 -3.570 (-28.18%)
    Streaming Delayed Price Updated: 11:05 AM EDT, Apr 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Oric Pharmaceuticals, Inc. - Common Stock

    < Previous 1 2 3 4 5 Next >
    These stocks are gapping in today's session ↗
    Via Chartmill
    Which stocks are moving before the opening bell on Wednesday? ↗
    Via Chartmill
    Top movers in Tuesday's after hours session ↗
    Via Chartmill
    News headline image
    Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. ↗
    Relay Therapeutics develops precision oncology medicines using proprietary computational modeling and strategic industry partnerships. 
    Via The Motley Fool
    News headline image
    Nextech Trims Kymera at a Recent High — think Foolishly before acting. ↗
    Kymera Therapeutics develops targeted protein degradation therapies for immunology and oncology, advancing a diversified clinical pipeline. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
    U.S. stock futures lower, with Dow futures down over 1%. BETA Technologies (NYSE: BETA) fell in pre-market trading after reporting fourth-quarter results. Other stocks declining in pre-market trading... 
    Via Benzinga
    Topics Stocks
    News headline image
    This Nasdaq Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗
     
    Via Benzinga
    News headline image
    This Bellring Brands Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday ↗
     
    Via Benzinga
    News headline image
    This Astera Labs Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
     
    Via Benzinga
    News headline image
    Nvidia To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday ↗
     
    Via Benzinga
    News headline image
    ORIC Pharmaceuticals Inc (NASDAQ:ORIC) Reports Q2 2025 Wider Loss but Extends Cash Runway with Strategic Restructuring ↗
    ORIC Pharmaceuticals reports Q2 2025 results with a wider loss but extends cash runway to 2H 2028. Updates on ORIC-944 and enozertinib show progress in oncology trials. 
    Via Chartmill
    News headline image
    Oric Pharma Stock Hits 3-Month High On Promising Results In Prostate Cancer Trial ↗
    The company also announced a $125 million private placement to fund its upcoming Phase 3 trial for ORIC-944 in metastatic prostate cancer. 
    Via Stocktwits
    News headline image
    Crude Oil Falls Over 1%; Best Buy Reports Downbeat Results ↗
     
    Via Benzinga
    News headline image
    Keep an eye on the top gainers and losers in Thursday's session. ↗
    Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
    Via Chartmill
    News headline image
    ORIC Pharmaceuticals Touts Positive Efficacy, Safety Data From Early-Stage Prostate Cancer Candidate, Raises Capital ↗
    ORIC's Phase 1b trial of ORIC-944 in mCRPC shows PSA responses and strong tolerability, with Phase 3 trials and financing plans underway. 
    Via Benzinga
    News headline image
    The market is filled with gapping stocks in Thursday's session. ↗
    Today's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
    Via Chartmill
    News headline image
    Veeva Systems, e.l.f. Beauty, C3.ai, BRP And Other Big Stocks Moving Higher On Thursday ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Why Nvidia Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Get insights into the top gainers and losers of Wednesday's after-hours session. ↗
    As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
    Via Chartmill
    News headline image
    Tuesday's session: gap up and gap down stocks ↗
    Let's have a look at the gap up and gap down stocks in today's session. 
    Via Chartmill
    News headline image
    H&E Equipment Services, ACM Research, Robinhood And Other Big Stocks Moving Higher On Tuesday ↗
     
    Via Benzinga
    News headline image
    PriceSmart Posts Weak Earnings, Joins Roku And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
    ORIC Pharmaceuticals is a stock analyst price targets currently signal double-bagger potential in. See what the excitement around this firm is all about. 
    Via MarketBeat
    News headline image
    ORIC Stock Earnings: ORIC Pharmaceuticals Misses EPS for Q2 2024 ↗
    ORIC stock results show that ORIC Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    News headline image
    ORIC Stock Earnings: ORIC Pharmaceuticals Beats EPS for Q1 2024 ↗
    ORIC stock results show that ORIC Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    News headline image
    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗
    Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention. 
    Via Benzinga
    News headline image
    Micron To Rally Around 134%? Here Are 10 Top Analyst Forecasts For Thursday ↗
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
    Via Benzinga
    News headline image
    These Analysts Revise Their Forecasts On ORIC Pharmaceuticals After Q4 Results ↗
    ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported a loss for the fourth quarter on Monday. 
    Via Benzinga
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.